Patient assistance programs and the 340B Drug Pricing Program promise to improve the financial stability, better serve vulnerable patients, and decrease the burden of cost for uninsured patients. Our ...
Atlas Health taps into financial assistance programs for patients to help hospitals get paid. AI connects the money, patients and health systems. At any given time, there are more than 20,000 ...
Gilead’s U.S. Advancing Access ® patient assistance program was developed in conjunction with feedback from advocates in the HIV community. The program utilizes a rapid and simple process that ensures ...
Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study One potential solution to ease the ...
In the search to lower out-of-pocket costs for prescription drugs, consumers will encounter a number of different coupons, discounts and assistance programs available to them. They don't all work the ...
Limited evidence from a literature review suggests that co-pay assistance was associated with improved treatment persistence/adherence across various diseases, with indirect evidence suggesting ...
More than 1.2 million people in the U.S. are living with HIV. If left untreated, HIV can lead to AIDS. But with consistent medical treatment, HIV drugs can keep you healthy, and, if your HIV virus ...
Support is Available for Eligible U.S. Patients Who Have Lost Their Jobs and Health Insurance Coverage Due to the Pandemic Risks and uncertainties include but are not limited to, general industry ...
Imatinib was the first targeted therapy approved for the treatment of cancer. With its approval, it was immediately clear to Novartis that this breakthrough therapy would require an innovative ...
When Gury Doshi, MD, learned that a patient’s insurance didn’t cover her breast cancer medication, Doshi had a potential workaround. The patient could try to bypass the insurer and access the drug at ...
Financial support given to patients is receiving more demand in the US, totalling an estimated $15 billion, but are patient assistance programmes good for either patients or pharmaceutical companies, ...
Pharmaceutical companies are taking a lot of reflected heat in the uproar over the 5,000% price hike for a drug needed by AIDS patients. But so far, the industry’s method of making sure that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results